socalTECH

JUNE 11, 2012

The firm said the patents are related to medical devices, biologics and diagnostic techniques. Acacia owns a wide range of patents, and regularly pursues companies for licensing terms covering those patents.

Patents 140

Patents Research Technology Company 140

socalTECH

JUNE 29, 2017

Fund size: $60M (Okapi Ventures III) Managing Directors: Marc Averitt, Sharon Stevenson, Jeff Bocan, John Waller Investment interests: Seed and early-stage companies in the technology and healthcare IT sectors and has also invested in medical device and medical diagnostic startups. Fika Ventures. Fund size: $40M.

Southern California 178

Southern California Venture Capital Artificial Inteligence Capital 178

SoCal Tech Calendar

SEPTEMBER 8, 2011

MEDevice is your best resource for every stage of biotech and medical device and diagnostic development. Wednesday, September 14, 2011 -- MEDevice Forum San Diego. This inaugural event boasts everything you need to improve product quality and reliability, shorten time-to-market, reduce costs, and enhance patient safety.

San Diego 113

San Diego Resource Marketing Product 113

SoCal Tech Calendar

SEPTEMBER 7, 2011

MEDevice is your best resource for every stage of biotech and medical device and diagnostic development. Tuesday, September 13, 2011 -- MEDevice Forum San Diego. This inaugural event boasts everything you need to improve product quality and reliability, shorten time-to-market, reduce costs, and enhance patient safety.

San Diego 113

San Diego Resource Marketing Product 113

TechCrunch LA

MAY 8, 2019

Imagine having diagnostics tools integrated with medical devices through software that can be distributed and updated remotely, giving practitioners the best quality information. That’s the goal for Pearl, Tanz says.

Artificial Inteligence 200

Artificial Inteligence Startup Yammer Los Angeles 200

SoCal Tech Calendar

OCTOBER 16, 2008

Wednesday, October 22, 2008 -- October Medical Device Event. Join us for an engaging discussion on Device and Diagnostic Development from Concept to Bedside. Confirmed Panelist: Richard Meyst, President/CEO, Fallbrook Engineering, Inc. See [link] (more).

Develop 100

Develop Development 100

Tech Zulu Event

JUNE 25, 2014

I actually came from a medical device background. I work at a medical device company, where we did a lot of urine testing. A diagnostics tool which can help catch some common diseases in the very dogs and cats we care for and warn pet owners about any health issues that may arise and seek early treatment.

Sample 74

Sample Startup Tool Mobile 74

Xconomy

JUNE 22, 2016

The healthcare computing giant, now headquartered in Cambridge, MA , is unveiling a collaborative effort in medical imaging that includes partnerships with health systems, radiology providers, tech companies, and academic medical centers.

IBM 61

IBM IBM Artificial Inteligence San Diego 61

Xconomy

JULY 5, 2016

The impact on in-state residents is huge, too: More than 56,500 people work at nearly 1,700 companies throughout Indiana in the sectors of medical care, drugs and pharmaceuticals, medical devices and equipment, research and testing laboratories, and the like. Warsaw, IN, is the “Orthopedic Capital of the World.”.

Patents 67

Patents Research Anthem Education 67

Xconomy

JUNE 30, 2016

Likewise with medical devices and diagnostics, which currently are under a third division’s jurisdiction. FDA commissioner Rob Califf recently predicted that many future treatments will combine drugs and data-enabled devices. One of the moonshot’s goals is to pack 10 years of work into five.

San Diego 65

San Diego Blogging Research Product 65

Xconomy

JUNE 3, 2016

Sandy Macrae, most recently the chief medical officer of Takeda Pharmaceutical, is now CEO and president. Richmond, CA-based Sangamo Biosciences (NASDAQ: SGMO ), the only gene editing firm to advance a treatment into clinical trials, said its founder president and CEO Edward Lanphier would hand over the reins but keep his board seat.

San Diego 62

San Diego Patents Acquisition News 62

Xconomy

AUGUST 28, 2020

Among the casualties of the COVID-19 pandemic: the credibility of government agencies entrusted with protecting public health. The FDA this week granted emergency use authorization for convalescent plasma as a treatment for infection by the novel coronavirus.

Funding 136

Funding Services San Diego Blogging 136

Xconomy

DECEMBER 3, 2019

Veracyte, a company whose tests help physicians make treatment decisions, is adding technology from NanoString to the fold to expand its diagnostic capabilities. The nCounter is a NanoString (NASDAQ: NSTG ) instrument used to analyze the activity of genes.

Activity 98

Activity Help Technology Develop 98

Tech.Co

MARCH 1, 2018

Their first product LexiconMD helped healthcare professionals dictate their notes into e-medical records hands- and eyes- free. The company has over 80 types of tests within wellness, diagnostics or drug testing, and their system generates results within minutes to the mobile app. LexiconAI (San Francisco, CA).

Startup 80

Startup Mentor Platform Help 80

Xconomy

FEBRUARY 14, 2018

The FDA has approved the first blood test to help diagnose concussions, clearing a path to the market for a diagnostic that could reduce the use of expensive brain imaging technologies that expose patients to radiation. The approval goes to San Diego diagnostics developer Banyan Biomarkers.

San Diego 102

San Diego Outsource Development Help Marketing 102

Xconomy

SEPTEMBER 18, 2020

Gilead Sciences CEO Daniel O’Day has spoken openly about acquisitions as a way to build up the company’s drug pipeline. This week, it made its biggest buy yet. The $21 billion Immunomedics acquisition brings to Gilead a cancer drug that many analysts project will become a blockbuster seller.

Class 67

Class Acquisition LAVA San Diego 67

Xconomy

SEPTEMBER 6, 2019

Being first to market with a new type of drug brings advantages. The first mover sets the bar for what physicians, payers, and patients can expect of that medicine and how much it costs. It grabs market share that followers have to steal away. But the first mover isn’t infallible if someone else has something better. is counting on.

Pricing 84

Pricing Class Study Marketing 84

Xconomy

NOVEMBER 29, 2018

San Diego’s Connect, which runs a tech and life science company accelerator, recognized seven local companies Thursday night at its 31st annual Most Innovative New Product Awards (MIP) gala. Winners were selected from among 23 finalists that were picked from all the companies that submitted products for consideration in the spring.

Product 92

Product San Diego Company Companies 92

Xconomy

FEBRUARY 22, 2019

The growing epidemic of the fatty liver disease known as NASH, which has no FDA-approved treatment, has led to a frenzied race among drug companies. This week, one company, Intercept Pharmaceuticals, solidified its lead. But how much will being first to the finish line mean when all is said and done?

News 86

News Study Report San Diego 86

Xconomy

JANUARY 3, 2018

Genalyte, a biomedical diagnostics company that has maintained a low profile in San Diego while raising almost $92 million, is getting ready to debut technology that targets a market long dominated by centralized lab services providers. Read more » Reprints | Share:

Services 83

Services San Diego Sample Technology 83

Xconomy

SEPTEMBER 27, 2019

Lung injuries linked to electronic cigarettes have topped 800 cases , including 12 deaths, according to the Centers for Disease Control and Prevention.

News 77

News Activity Product Help 77

Xconomy

AUGUST 7, 2017

As an executive recruiter focused solely on life sciences, I’m among the first to acknowledge the industry’s gender gap. Of the 20 largest pharmaceutical companies around the world, only one has a woman at the helm—and GSK named Emma Natasha Walmsley as CEO less than five months ago.

Guide 78

Guide San Diego Company Companies 78

Xconomy

NOVEMBER 7, 2017

Progenity, a San Diego molecular diagnostics company focused on women’s health, reproductive medicine, and oncology, has raised $125 million in a Series B financing led by New York’s Athyrium Capital Management, an earlier investor. The company says it has developed a portfolio of diagnostic tests for pre-eclampsia, genetic carrier.

San Diego 52

San Diego Equity Capital Develop 52

Xconomy

APRIL 6, 2017

[ Updated 4/6/17, 7:42 pm. Consumers who aren’t squeamish about spitting into a tube and sending it to a lab can now have 23andMe test those samples to assess their risk of developing Parkinson’s, Alzheimer’s, and eight other disorders.

Sample 59

Sample Marketing Startup Develop 59